Yew Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 25 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -7.84%
(FY 2023)
- Profit 1.78%
(FY 2023)
- Ebitda 304.33%
(FY 2023)
- Net Worth -17.54%
(FY 2023)
- Total Assets -7.83%
(FY 2023)
About Yew Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jayantilal Vekaria and Nayanaben Ramotia serve as directors at the Company.
- CIN/LLPIN
U24231GJ1999PTC035849
- Company No.
035849
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Apr 1999
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- LocationRajkot, Gujarat
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Yew Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayantilal Vekaria  | Director | 01-Feb-2009 | Current |
| Nayanaben Ramotia | Director | 26-Apr-1999 | Current |
Financial Performance of Yew Pharma.
Yew Pharma Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 7.84% decrease. The company also saw a slight improvement in profitability, with a 1.78% increase in profit. The company's net worth observed a substantial decline by a decrease of 17.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Yew Pharma?
In 2023, Yew Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Panzer Pharmaceutical Private LimitedActive 27 years 6 monthsJayantilal Vekaria and Nayanaben Ramotia are mutual person
Onus Pharmaceutical Private LimitedActive 17 years 7 monthsJayantilal Vekaria and Nayanaben Ramotia are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Yew Pharma?
Yew Pharma has a workforce of 19 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Yew Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Yew Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
